Anti-atherosclerotic effect of a new synthetic functional oil containing mono- and diacylglycerol from corn oil

Annals of Nutrition and Metabolism

Volumn 50, Issue 5, 2006, Pages 467-475

  Cho, Kyung Hyun ^a   Han, Jong Min ^b   Jeong, Tae Sook ^b   Kim, Hyoung Chin ^b   Lee, Jong Ho ^c   Lee, Jeung Hee ^d   Lee, Ki Teak ^d  

^a Yeungnam University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Yonsei University   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Atherosclerosis; Diacylglyceride; Hypercholesterolemia; Lipoproteins; Monoacylglyceride

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CORN OIL; DIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; MONOACYLGLYCEROL; PHOSPHOLIPASE A2;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME INHIBITION; HYPERCHOLESTEROLEMIA; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, HDL; CORN OIL; DIGLYCERIDES; DISEASE MODELS, ANIMAL; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MONOGLYCERIDES; PHOSPHOLIPASES A; PHOSPHOLIPASES A2; RANDOM ALLOCATION; STEROL O-ACYLTRANSFERASE;

ZEA MAYS;

EID: 33748973202     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095353     Document Type: Article

References (29)

1. Murase T, Mizuno T, Omachi T, Onizawa K, Komine Y, Kondo H, Hase T, Tokimitsu I: Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice. J Lipid Res 2001;42:372-378.
2. Meguro S, Hase T, Otsuka A, Tokimitsu I, Itakura H: Effect of phytosterols in dietary diacylglycerol on atherosclerosis in cholesterol-fed rabbits. Nutrition 2003;19:670-675.
3. Maki KC, Davidson MH, Tsusima R, Matsuo N, Tokimitsu I, Umporowicz DM, Dicklin MR, Foster GS, Ingram KA, Anderson BD, Frost SD, Bell M: Consumption of diacylglycerol oil as part of a reduced-energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. Am J Clin Nutr 2002;76:1230-1236.
4. Murase T, Aoki M, Wakisaka T, Hase T, Tokimitsu I: Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism. J Lipid Res 2002;43:1312-1319.
5. Thumser AEA, Buckland AG, Wilton DC: Monoacylglycerol binding to human serum albumin: evidence that monooleoylglycerol binds at the dansylsarcosine site. J Lipid Res 1998;39:1033-1038.
6. Murota K, Matsui N, Kawada T, Takahashi N, Fushuki T: Inhibitory effect of monoacylglycerol on fatty acid uptake into rat intestinal epithelial cells. Biosci Biotechnol Biochem 2001;65:1441-1443.
7. Ho SY, Storch J: Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells. Am J Physiol 2001;281:C1106-C1117.
8. Ho SY, Delgado L, Storch J: Monoacylglycerol metabolism in human intestinal Caco-2 cells. J Biol Chem 2002;277:1816-1823.
9. Flickinger BD, Matsuo N: Nutritional characteristics of DAG oil. Lipids 2003;38:129-132.
10. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M: Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 1995;44:645-651.
11. Parekh PI, Petro AE, Tiller JM, Feinglos MN, Surwit RS: Reversal of diet-induced obesity and diabetes in C57BL/6J mice. Metabolism 1998;47:1089-1096.
12. Lee KT, Jones KC, Foglia TA: Separation of structured lipids by high-performance liquid chromatograph. Chromatographia 2002; 55:197-202.
13. Brecher P, Chan CT: Properties of acyl-CoA: cholesterol O-acyltransferase in aortic microsomes from atherosclerotic rabbits. Biochim Biophys Acta 1980;617:458-471.
14. Cho KH, An S, Lee WS, Paik YK, Kim YK, Jeong TS: Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation. Biochem Biophys Res Commun 2003;309:864-872.
15. Stafforini DM, Prescott SM, McIntyre TM: Human plasma platelet-activating factor acetylhydrolase: purification and properties. J Biol Chem 1987;262:4223-4230.
16. McCall MR, Belle ML, Forte TM, Krauss RM, Takanami Y, Tribble DL: Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. Biochim Biophys Acta 1999;1437:23-26.
17. Han JM, Jeong TS, Lee WS, Choi I, Cho KH: Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J Lipid Res 2005;46:589-596.
18. Matz CE, Jonas A: Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J Biol Chem 1982;257:4535-4540.
19. Cho KH, Durbin D, Jonas A: Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements. J Lipid Res 2001;42:379-389.
20. Lee S, Han JM, Kim H, Kim E, Jeong TS, Lee WS, Cho KH: Synthesis of cinnamic acid derivatives and their inhibitory effects on LDL-oxidation, acyl-CoA: cholesterol acyltransferase-1 and -2 activity, and decrease of HDL particle size. Bioorg Med Chem Lett 2004;14: 4677-4681.
21. Noble RP: Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res 1968;9:693-700.
22. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
23. Markwell MAK, Haas SM, Bieber LL, Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978;87:206-210.
24. Erickson SK, Shrewsbury MA, Brooks C, Meyer DJ: Rat liver acyl-coenzyme A:cholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. J Lipid Res 1980;21:930-941.
25. Jonas A, Kédzy KE, Wald JH: Defined apolipoprotein A-I conformations in reconstituted high density lipoprotein discs. J Biol Chem 1989;264:4818-4824.
26. 2: a potential new risk factor for coronary artery disease and a therapeutic target. Curr Opin Pharmacol 2001;1:121-125.
27. 2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med 2000;343:1148-1155.
28. 2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999;19:2909-2917.
29. 2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor. Biochem J 1999;338:479-487.